Literature DB >> 27618856

V122I TTR Cardiac Amyloidosis in Patients of African Descent: Recognizing a Missed Disease or the Dog That Didn't Bark?

Kevin M Alexander1, Rodney H Falk2.   

Abstract

Entities:  

Keywords:  Editorials; cardiomyopathy; echocardiography; heart failure; myocardium; primaryamyloidosis

Mesh：

Substances：

Year:  2016        PMID： 27618856     DOI： 10.1161/CIRCHEARTFAILURE.116.003489

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  3 in total

1.  Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.

Authors:  Mark Miller; Arindom Pal; Wabel Albusairi; Hyun Joo; Beverly Pappas; Md Tariqul Haque Tuhin; Dengpan Liang; Raghavendra Jampala; Fang Liu; Jared Khan; Marjon Faaij; Miki Park; William Chan; Isabella Graef; Robert Zamboni; Neil Kumar; Jonathan Fox; Uma Sinha; Mamoun Alhamadsheh
Journal:  J Med Chem       Date:  2018-08-22       Impact factor: 7.446

2.  Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.

Authors:  Volha Skrahina; Ulrike Grittner; Christian Beetz; Thomas Skripuletz; Martin Juenemann; Heidrun H Krämer; Katrin Hahn; Andreas Rieth; Volker Schaechinger; Monica Patten; Christian Tanislav; Stephan Achenbach; Birgit Assmus; Fabian Knebel; Stefan Gingele; Aliaksandr Skrahin; Jörg Hartkamp; Toni M Förster; Sabine Roesner; Catarina Pereira; Arndt Rolfs
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

3.  Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.

Authors:  Christopher L Cioffi; Parthasarathy Muthuraman; Arun Raja; Andras Varadi; Boglarka Racz; Konstantin Petrukhin
Journal:  J Med Chem       Date:  2020-09-17       Impact factor: 8.039
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.